Descriptor English: | Fosinopril | ||||||
Descriptor Spanish: |
Fosinopril
| ||||||
Descriptor Portuguese: | Fosinopril | ||||||
Descriptor French: | Fosinopril | ||||||
Entry term(s): |
Dynacil Fosenopril Fosinil Fosinopril Sodium Fosinopril, (1(S*(R*)),2 alpha,4 alpha)-(D-Pro)-Isomer Fosinopril, (1(S*(R*)),2 alpha,4 beta)-Isomer Fosinopril, (1(S*(S*)),2 alpha,4 beta)-Isomer Fosinorm Fositens Fozitec Hiperlex Monopril Newace SQ 28,555 SQ 28555 SQ-28,555 SQ-28555 SQ28,555 SQ28555 Sodium, Fosinopril Staril Tenso Stop Tensocardil |
||||||
Tree number(s): |
D02.705.629.500 D12.125.072.401.623.374 |
||||||
RDF Unique Identifier: | https://id.nlm.nih.gov/mesh/D017328 | ||||||
Scope note: | A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat. |
||||||
Allowable Qualifiers: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||||
Pharm Action: |
Angiotensin-Converting Enzyme Inhibitors Antihypertensive Agents |
||||||
Registry Number: | R43D2573WO | ||||||
CAS Type 1 Name: | L-Proline, 4-cyclohexyl-1-(((2-methyl-1-(1-oxopropoxy)propoxy)(4-phenylbutyl)phosphinyl)acetyl)-, (1(S*(R*)),2alpha,4beta)- | ||||||
Previous Indexing: |
Proline/analogs & derivatives (1985-1992) |
||||||
Public MeSH Note: | 93; FOSENOPRIL was indexed under PROLINE/analogs & derivatives 1985-92 |
||||||
Online Note: | use FOSINOPRIL (NM) to search FOSENOPRIL 1985-92 |
||||||
History Note: | 93; was FOSENOPRIL (NM) 1985-92 |
||||||
DeCS ID: | 30725 | ||||||
Unique ID: | D017328 | ||||||
Documents indexed in the Virtual Health Library (VHL): | Click here to access the VHL documents | ||||||
Date Established: | 1993/01/01 | ||||||
Date of Entry: | 1992/05/20 | ||||||
Revision Date: | 2016/07/01 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Amino Acids, Peptides, and Proteins [D12]Amino Acids, Peptides, and Proteins
|
Fosinopril
- Preferred
Fosinil
- Narrower
Fosinopril Sodium
- Narrower
Fosinopril, (1(S*(R*)),2 alpha,4 alpha)-(D-Pro)-Isomer
- Related but not broader or narrower
Tenso Stop
- Narrower
Fozitec
- Narrower
Hiperlex
- Narrower
Monopril
- Narrower
SQ-28,555
- Narrower
Dynacil
- Narrower
Fosinopril, (1(S*(S*)),2 alpha,4 beta)-Isomer
- Related but not broader or narrower
Concept UI |
M0026315 |
Scope note | A phosphinic acid-containing angiotensin-converting enzyme inhibitor that is effective in the treatment of hypertension. It is a prodrug that is converted to its active metabolite fosinoprilat. |
Preferred term | Fosinopril |
Entry term(s) |
Fosenopril |
Concept UI |
M0482928 |
Preferred term | Fosinil |
Entry term(s) |
Fositens |
Concept UI |
M0026317 |
Preferred term | Fosinopril Sodium |
Entry term(s) |
Fosinopril, (1(S*(R*)),2 alpha,4 beta)-Isomer Sodium, Fosinopril |
Concept UI |
M0329308 |
Preferred term | Fosinopril, (1(S*(R*)),2 alpha,4 alpha)-(D-Pro)-Isomer |
Concept UI |
M0482930 |
Preferred term | Tenso Stop |
Entry term(s) |
Tensocardil |
Concept UI |
M0482927 |
Preferred term | Fozitec |
Concept UI |
M0482931 |
Preferred term | Hiperlex |
Concept UI |
M0352132 |
Preferred term | Monopril |
Entry term(s) |
Fosinorm Newace Staril |
Concept UI |
M0352131 |
Preferred term | SQ-28,555 |
Entry term(s) |
SQ 28,555 SQ 28555 SQ-28555 SQ28,555 SQ28555 |
Concept UI |
M0482929 |
Preferred term | Dynacil |
Concept UI |
M0329307 |
Preferred term | Fosinopril, (1(S*(S*)),2 alpha,4 beta)-Isomer |
We want your feedback on the new DeCS / MeSH website
We invite you to complete a survey that will take no more than 3 minutes.
Go to survey